OPTION RCT – TNK for Stroke at 4.5-24 Hours – Better Again
Spoon Feed —
Tenecteplase (TNK) vs. usual care in non-large vessel occlusion (non-LVO) stroke patients 4.5–24 hours from onset, with perfusion mismatch, had better outcome but slightly more intracranial hemorrhage.
Source
OPTION Investigators. Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke: The OPTION Randomized Clinical Trial. JAMA. 2026 Feb 5:e260210. doi: 10.1001/jama.2026.0210. Epub ahead of print. PMID: 41642827; PMCID: PMC12878635.
